LetterCorrespondence
Open Access
Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?
Abdulghani Alsaeed
Saudi Medical Journal January 2021, 42 (1) 116; DOI: https://doi.org/10.15537/smj.2021.1.25621
Abdulghani Alsaeed
Endocrine and Diabetes Department Prince Sultan Military Medical City Riyadh, Kingdom of Saudi Arabia
References
- ↵
- Sukkarieh HH,
- Bustami RT,
- Abdu MN,
- Khokhar AA,
- Salih AA,
- Abdalla HK
- ↵
- Olivarius Nde F,
- Andreasen AH,
- Keiding N,
- Mogensen CE
- ↵
- Standard of medical care in diabetes- 2020
- ↵
- Ponikowski P,
- Voors AA,
- Anker SD,
- Bueno H,
- Cleland JGF,
- Coats AJS,
- et al.
- ↵
- Fried LF,
- Emanuele N,
- Zhang JH,
- Brophy M,
- Conner TA,
- Duckworth W,
- et al.
- ↵
- AlFaris NA,
- AlKehayez NM,
- AlMushawah FI,
- AlNaeem AN,
- AlAmri ND,
- AlMudawah ES
In this issue
Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?
Abdulghani Alsaeed
Saudi Medical Journal Jan 2021, 42 (1) 116; DOI: 10.15537/smj.2021.1.25621
Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?
Abdulghani Alsaeed
Saudi Medical Journal Jan 2021, 42 (1) 116; DOI: 10.15537/smj.2021.1.25621
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.